Literature DB >> 33491560

WNK4 kinase: from structure to physiology.

Adrián Rafael Murillo-de-Ozores1,2, Alejandro Rodríguez-Gama3, Héctor Carbajal-Contreras1,4, Gerardo Gamba1,5,4, María Castañeda-Bueno1,4.   

Abstract

With no lysine kinase-4 (WNK4) belongs to a serine-threonine kinase family characterized by the atypical positioning of its catalytic lysine. Despite the fact that WNK4 has been found in many tissues, the majority of its study has revolved around its function in the kidney, specifically as a positive regulator of the thiazide-sensitive NaCl cotransporter (NCC) in the distal convoluted tubule of the nephron. This is explained by the description of gain-of-function mutations in the gene encoding WNK4 that causes familial hyperkalemic hypertension. This disease is mainly driven by increased downstream activation of the Ste20/SPS1-related proline-alanine-rich kinase/oxidative stress responsive kinase-1-NCC pathway, which increases salt reabsorption in the distal convoluted tubule and indirectly impairs renal K+ secretion. Here, we review the large volume of information that has accumulated about different aspects of WNK4 function. We first review the knowledge on WNK4 structure and enumerate the functional domains and motifs that have been characterized. Then, we discuss WNK4 physiological functions based on the information obtained from in vitro studies and from a diverse set of genetically modified mouse models with altered WNK4 function. We then review in vitro and in vivo evidence on the different levels of regulation of WNK4. Finally, we go through the evidence that has suggested how different physiological conditions act through WNK4 to modulate NCC activity.

Entities:  

Keywords:  blood pressure; distal convoluted tubule; distal nephron; epithelial transport; familial hyperkalemic hypertension; potassium

Mesh:

Substances:

Year:  2021        PMID: 33491560      PMCID: PMC7988811          DOI: 10.1152/ajprenal.00634.2020

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  187 in total

Review 1.  SGK1: aldosterone-induced relay of Na+ transport regulation in distal kidney nephron cells.

Authors:  François Verrey; Johannes Loffing; Marija Zecevic; Dirk Heitzmann; Olivier Staub
Journal:  Cell Physiol Biochem       Date:  2003

2.  Potassium intake modulates the thiazide-sensitive sodium-chloride cotransporter (NCC) activity via the Kir4.1 potassium channel.

Authors:  Ming-Xiao Wang; Catherina A Cuevas; Xiao-Tong Su; Peng Wu; Zhong-Xiuzi Gao; Dao-Hong Lin; James A McCormick; Chao-Ling Yang; Wen-Hui Wang; David H Ellison
Journal:  Kidney Int       Date:  2018-01-06       Impact factor: 10.612

3.  Kidney-specific WNK1 isoform (KS-WNK1) is a potent activator of WNK4 and NCC.

Authors:  Eduardo R Argaiz; Maria Chavez-Canales; Mauricio Ostrosky-Frid; Alejandro Rodríguez-Gama; Norma Vázquez; Xochiquetzal Gonzalez-Rodriguez; Jesus Garcia-Valdes; Juliette Hadchouel; David Ellison; Gerardo Gamba
Journal:  Am J Physiol Renal Physiol       Date:  2018-05-30

4.  Angiotensin II signaling via protein kinase C phosphorylates Kelch-like 3, preventing WNK4 degradation.

Authors:  Shigeru Shibata; Juan Pablo Arroyo; María Castañeda-Bueno; Jeremy Puthumana; Junhui Zhang; Shunya Uchida; Kathryn L Stone; TuKiet T Lam; Richard P Lifton
Journal:  Proc Natl Acad Sci U S A       Date:  2014-10-13       Impact factor: 11.205

Review 5.  The Renal Physiology of Pendrin-Positive Intercalated Cells.

Authors:  Susan M Wall; Jill W Verlander; Cesar A Romero
Journal:  Physiol Rev       Date:  2020-07-01       Impact factor: 37.312

6.  Impaired degradation of medullary WNK4 in the kidneys of KLHL2 knockout mice.

Authors:  Yuri Kasagi; Daiei Takahashi; Tomomi Aida; Hidenori Nishida; Naohiro Nomura; Moko Zeniya; Takayasu Mori; Emi Sasaki; Fumiaki Ando; Tatemitsu Rai; Shinichi Uchida; Eisei Sohara
Journal:  Biochem Biophys Res Commun       Date:  2017-04-14       Impact factor: 3.575

Review 7.  The WNKs: atypical protein kinases with pleiotropic actions.

Authors:  James A McCormick; David H Ellison
Journal:  Physiol Rev       Date:  2011-01       Impact factor: 37.312

8.  WNK1, a gene within a novel blood pressure control pathway, tissue-specifically generates radically different isoforms with and without a kinase domain.

Authors:  Michelle O'Reilly; Elaine Marshall; Helen J L Speirs; Roger W Brown
Journal:  J Am Soc Nephrol       Date:  2003-10       Impact factor: 10.121

9.  A mouse model of pseudohypoaldosteronism type II reveals a novel mechanism of renal tubular acidosis.

Authors:  Karen I López-Cayuqueo; Maria Chavez-Canales; Alexia Pillot; Pascal Houillier; Maximilien Jayat; Jennifer Baraka-Vidot; Francesco Trepiccione; Véronique Baudrie; Cara Büsst; Christelle Soukaseum; Yusuke Kumai; Xavier Jeunemaître; Juliette Hadchouel; Dominique Eladari; Régine Chambrey
Journal:  Kidney Int       Date:  2018-07-07       Impact factor: 10.612

10.  The CUL3-KLHL3 E3 ligase complex mutated in Gordon's hypertension syndrome interacts with and ubiquitylates WNK isoforms: disease-causing mutations in KLHL3 and WNK4 disrupt interaction.

Authors:  Akihito Ohta; Frances-Rose Schumacher; Youcef Mehellou; Clare Johnson; Axel Knebel; Thomas J Macartney; Nicola T Wood; Dario R Alessi; Thimo Kurz
Journal:  Biochem J       Date:  2013-04-01       Impact factor: 3.857

View more
  3 in total

Review 1.  Potassium homeostasis: sensors, mediators, and targets.

Authors:  Alicia A McDonough; Robert A Fenton
Journal:  Pflugers Arch       Date:  2022-06-21       Impact factor: 4.458

2.  Low-salt diet increases mRNA expression of aldosterone-regulated transporters in the intermediate portion of the endolymphatic sac.

Authors:  Ai Matsubara; Takenori Miyashita; Kentaro Nakashima; Nozomu Mori; Si-Young Song; Hiroshi Hoshikawa
Journal:  Pflugers Arch       Date:  2022-02-03       Impact factor: 3.657

Review 3.  Molecular mechanisms for the modulation of blood pressure and potassium homeostasis by the distal convoluted tubule.

Authors:  María Castañeda-Bueno; David H Ellison; Gerardo Gamba
Journal:  EMBO Mol Med       Date:  2021-12-20       Impact factor: 12.137

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.